NewsRoom Articles - Page 596 of 1444

MondayOct 05, 2020 12:52 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in the Phase I trial has remained cancer-free over the course of 14 years, and 44 percent of the patients who could be evaluated experienced a clinically significant positive response to Berubicin CNS’s laser-focused strategy for developing a GBM therapy is also leading the company to…

MondayOct 05, 2020 12:28 pm

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…

MondayOct 05, 2020 11:35 am

Sugarmade (SGMD) 8K Filing Notes Status, Potential of Upcoming LA-Based Cannabis-Delivery Locations

SGMD has filed updated Form 8K Current Report with SEC Filing includes information about issues related to company’s status, including planned expansion of BudCars cannabis-delivery service Sugarmade sees “major business opportunities out of both sites once operations begin” Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has released the publication of a Form 8K Current Report filing with the United States Securities and Exchange Commission (“SEC”) (http://nnw.fm/g3JHV). The filing includes specific information about several issues related to the company’s performance and outlook, including planned expansion of the BudCars cannabis delivery service.…

MondayOct 05, 2020 10:58 am

Rritual Mushrooms Inc. is “One to Watch”

Rritual’s suite of premium functional mushroom and adaptogenic elixirs is designed to offer various health benefits, such as increased immunity, cognitive function, stress management and more The company’s products are expected to be available online through Rritual’s site and Amazon by fall 2020 The Rritual team has extensive ties and influential relationships with leading retail businesses, providing a wide market for growth The functional mushroom industry has no clear and dominant leader, allowing Rritual to target this role with its premium products. Rritual is currently the only premium brand on the market The global functional mushroom market is expected to…

FridayOct 02, 2020 12:13 pm

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in Rapidly Growing Mushroom Space

Research shows psilocybin produces immediate, substantial and sustained improvements in anxiety and depression Global medicinal mushroom market projected to increase by almost $14 billion annually for the next several years Pure Extracts is a plant-based extraction company with new vertical in the mushroom space Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in treating depression, a debilitating disorder that plagues an estimated 300 million people in the United State. Psilocybin is the main psychoactive ingredient in “magic” mushrooms. With growing interest in the mushroom sector — both psychedelic and functional — companies such as Pure Extract Technologies could see exciting…

FridayOct 02, 2020 11:50 am

The Wild West Crypto Show Hosts Crypto Crusaders Dirk Leuth and Ronnie Moas

It’s been another week at the speed of crypto as developments in the space continue to unfold rapidly. During episode 127, “Upland Brings Virtual Gaming to Blockchain,” Wild West Crypto Show hosts Drew Taylor and Brent Bates caught up with Dirk Leuth and Ronnie Moas. Moas has been on the show before. The founder of Standpoint Research, he is well known in financial circles, having published more than 900 articles about stocks and shares. Leuth heads Californian start-up Upland, which he founded. Upland has created a parallel world where users can play, operate businesses and connect with fellow Uplanders. Members…

FridayOct 02, 2020 11:26 am

New Seattle Law Adds to Regulatory Challenges for Ride-share Companies Such as Uber Technologies Inc. (NYSE: UBER)

Peer-to-peer transportation pioneer Uber Technologies has found its global brand increasingly embattled during the COVID-19 pandemic amid declining ridership and increasing regulatory hurdles to its independent contractor payment model Seattle recently passed legislation imposing a sliding scale payment model on such companies to ensure drivers receive the equivalent of minimum wage, even if they are spending some down time between ride services. The law is based on a New York City decision imposed in 2018, which has shored up drivers’ sense of security but has reduced the number of drivers in use, increasing fare costs and wait times Uber is…

FridayOct 02, 2020 10:43 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) is “One to Watch”

VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for the treatment of social anxiety disorder, major depressive disorder and neuropathic pain. The global CNS therapeutics market is estimated to reach $130 billion by 2025 The two most common mental health conditions – anxiety and depression – cost the global economy an estimated $1 trillion each year VistaGen is committed to developing and commercializing multiple new generation medications that go beyond the standard of care…

FridayOct 02, 2020 9:00 am

Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation

NetworkNewsWire Editorial Coverage: Innovation and breakthroughs in the biotech industry are essential to identifying and providing life-saving treatments. Companies that invest substantial amounts of time, effort, and resources in key areas of research and innovation are critical in the advancement treatment options across the board. On the front lines of research and development in the area of inflammation, which typically occurs in the body as a natural response to threats such as infection or injury can cause severe damage and even death, is 180 Life Sciences Corp. (NASDAQ: KBLM) (NASDAQ: KNLMR) (NASDAQ: KBLMW) (180 Profile). The company is focused on…

ThursdayOct 01, 2020 3:17 pm

Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure

The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an increased exposure to potential investors in September, by attending several virtual investor events and conferences, where it was given the opportunity to present its innovative platform and its advantages for pharmacy members. The company started the last month of the third fiscal quarter strong by…

Financial news and publishing for public and private companies

Contact us: 512.354.7000